ContractHla/Aav Sublicence Agreement • March 17th, 2016 • Adaptimmune Therapeutics PLC • Biological products, (no disgnostic substances) • Washington
Contract Type FiledMarch 17th, 2016 Company Industry Jurisdiction***Certain portions of this exhibit have been omitted based on a request for confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended. The omitted portions have been filed separately with the Securities and Exchange Commission.